Presentation THT 2025 Medical Management (Heparin/ Lytics) Presenter: Gregory Piazza February 12, 2025
Presentation TCT 2024 TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study Presenter: Neethi Dasu October 30, 2024
Presentation TCT 2024 TCT 235: Efficacy and Safety of Bivalirudin and Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients Who Underwent Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis Presenter: Hamza Naveed October 28, 2024
Presentation TCT 2024 TCT 934: Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial Presenter: Jing Chen October 28, 2024
Presentation TCT 2024 Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial Presenter: Jing Chen October 28, 2024
Presentation TCT 2024 Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial Presenter: Jing Chen October 28, 2024
Presentation TCT 2024 TCT 182: Impact of Heparin-Induced Thrombocytopenia (HIT) on Outcomes in TAVR Patients: A Comprehensive Analysis Presenter: Neethi Dasu October 27, 2024
Presentation THT 2024 Catheters Are Over-Rated! Heparin as the Primary Option Presenter: Sanjum S. Sethi March 06, 2024
Presentation CTO 2024 Heparinised Saline Usage for Optical Coherence Tomography Intravascular Imaging, Safety and Efficancy Assessment of Suggested Heparinised Saline Injections Protocol With Automatic Pump Injector Presenter: Aiste Zebrauskaite February 03, 2024
Presentation TCT 2023 TCT 215: Safety of Bivalirudin Versus Heparin in Patients With ST-elevation Myocardial Infarction: a Systematic Review and Meta-analysis: Presenter: Mostafa Elbanna October 26, 2023
Presentation TCT 2023 TCT 538: Comparison of Limb Outcome between Hemodialysis and Non-hemodialysis Patients following Heparin-bonded Stent Graft Implantation for Femoropopliteal Lesion from LANDMARK registry Presenter: Kazuki Tobita October 25, 2023
Presentation TCT 2023 TCT 42: Does Heparin-induced thrombocytopenia affect in-hospital outcomes in patients presenting with ST-segment elevation myocardial infarction? A nationwide data analysis. Presenter: Purveshkumar Patel October 25, 2023
Presentation TCT 2023 Unfractionated Heparin Still Works for Primary PCI! Presenter: Rod Stables October 25, 2023
Presentation TCT 2023 Debate: Intermediate-Risk Pulmonary Embolism — No Data for Catheters, Stick With Heparin! Presenter: Ido Weinberg October 25, 2023
Presentation AHA 2022 Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial Presenter: Gregg W. Stone November 07, 2022
Presentation TCT 2022 TCT 590: Comparison of Different Doses of Heparin on Prevention of Radial Artery Occlusion After Diagnostic Transradial Catheterization Presenter: Jose Costa Jr September 19, 2022
Presentation TCT 2020 Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin Versus Heparin in Acute Myocardial Infarction Presenter: Gregg Stone October 14, 2020
Presentation TCT 2020 TCT 521: Biventricular Impella Support in a Patient With Cardiogenic Shock and Heparin-Induced Thrombocytopenia and Thrombosis Presenter: Joshua Aymond October 14, 2020
Presentation TCT Abstracts Posters 2018 Heparin surfaces: Impact of immobilization chemistry for blood contact performance Presenter: Jennie Forsberg September 25, 2018
Presentation TCT Abstracts Posters 2018 Effects of Access Site on Safety and Efficacy of Bivalirudin Compared to Heparin in Acute Coronary Syndrome: A Meta-analysis of Randomized Control Trials Presenter: Amit Rout September 25, 2018